Treating Postmenopausal Dyspareunia Where it Hurts

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the effectiveness of two low doses of estrogen cream applied to a new location for the treatment of moderate or severe pain during sexual intercourse in postmenopausal women.

Clinical Trial Description

Estrogen cream is FDA-approved for vaginal use for the treatment of sexual pain, but its use in a new location is experimental. Pain with sex is a common problem experienced by women after menopause and the relationship of pain to sexual difficulties is well established. The cause has been assumed to be atrophy and the location has been assumed to be the vagina. Recent focused studies have shown that the location of pain is the vulvar vestibule and usually not the vagina. This study will look at pain before and after therapy with estrogen when only the vulvar entryway area is treated. This will be a study focused on sexual dysfunction in postmenopausal women. ;

Study Design

Related Conditions & MeSH terms

Dyspareunia

Clinical Trial Details

NCT number	NCT03240081
Study type	Interventional
Source	Oregon Health and Science University
Contact
Status	Completed
Phase	Phase 4
Start date	June 20, 2017
Completion date	November 21, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03935698` - Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study	N/A
Recruiting	`NCT03427255` - CBT Group Treatment for Women With Dyspareunia	N/A
Completed	`NCT02253173` - Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women	Phase 3
Completed	`NCT03184077` - Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair	N/A
Recruiting	`NCT05445115` - The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device	N/A
Withdrawn	`NCT03666819` - Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy	Phase 2
Active, not recruiting	`NCT03681678` - Laser Therapy for Treatment of Urogenital Symptoms in Women
Completed	`NCT04955418` - Effects of Epi-no Device on Pelvic Floor Dysfunctions	N/A
Completed	`NCT05834088` - Effects of Myofascial Release With and Without Thiele Massage	N/A
Terminated	`NCT03185169` - GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors	Early Phase 1
Completed	`NCT03307044` - Fractional CO2 Laser Therapy for Survivors of Breast Malignancies	N/A
Completed	`NCT05617820` - Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy	Phase 3
Recruiting	`NCT03714581` - Laser Therapy Following Radiotherapy for Gynecological Cancer	N/A
Completed	`NCT04659668` - Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.	N/A
Completed	`NCT03199534` - A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction	Phase 4
Completed	`NCT00318500` - Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women	Phase 2
Recruiting	`NCT05540353` - Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients With Endometriosis.	N/A
Completed	`NCT03178825` - Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause	N/A
Completed	`NCT04389489` - Postpartum Sexual Function in Pregnant Women With COVID-19
Completed	`NCT03372720` - Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors	N/A